Home NDC 70518-1936-0 Latuda
Product NDC 70518-1936
Requested package NDC 70518-1936-0
11-digit product format 705181936
Labeler code 70518
Product ID 70518-1936_ba9db2b8-c058-59ce-e053-2995a90a2971
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name lurasidone hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler REMEDYREPACK INC.
Application NDA200603
Marketing category NDA
Marketing start 2019-03-06
Marketing end 0000-00-00
Substance LURASIDONE HYDROCHLORIDE
Active strength 120 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N200603-001 LATUDA LURASIDONE HYDROCHLORIDE 40MG TABLET / ORAL AB RLD, RS 2010-10-28 N200603-002 LATUDA LURASIDONE HYDROCHLORIDE 80MG TABLET / ORAL AB RLD 2010-10-28 N200603-003 LATUDA LURASIDONE HYDROCHLORIDE 20MG TABLET / ORAL AB RLD 2011-12-07 N200603-004 LATUDA LURASIDONE HYDROCHLORIDE 120MG TABLET / ORAL AB RLD 2012-04-26 N200603-005 LATUDA LURASIDONE HYDROCHLORIDE 60MG TABLET / ORAL AB RLD 2013-07-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 55 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 205 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 6 · 205 observed states.
Observed Orange Book patent history# Patent history page 1 of 82 · 3,275 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N200603-001 8729085 2026-05-26 Drug product 2014-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 8883794 2026-05-26 Drug product 2014-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9555027 2026-05-26 U-543 Drug product 2017-03-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9907794 2026-05-26 Drug product 2018-03-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 8729085*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 8883794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9907794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9259423 2031-05-23 U-1822 2016-03-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9827242 2031-05-23 U-2199 2017-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9827242 2031-05-23 U-2201 2017-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-001 9259423*PED 2031-11-23 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 8729085 2026-05-26 Drug product 2014-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 8883794 2026-05-26 Drug product 2014-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9555027 2026-05-26 U-543 Drug product 2017-03-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9907794 2026-05-26 Drug product 2018-03-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 8729085*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 8883794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9907794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9259423 2031-05-23 U-1822 2016-03-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9827242 2031-05-23 U-2201 2017-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9827242 2031-05-23 U-2199 2017-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 9259423*PED 2031-11-23 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 8729085 2026-05-26 Drug product 2014-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 8883794 2026-05-26 Drug product 2014-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9555027 2026-05-26 U-543 Drug product 2017-03-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9907794 2026-05-26 Drug product 2018-03-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 8729085*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 8883794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9907794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9259423 2031-05-23 U-1822 2016-03-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9827242 2031-05-23 U-2199 2017-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9827242 2031-05-23 U-2201 2017-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 9259423*PED 2031-11-23 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 8729085 2026-05-26 Drug product 2014-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 8883794 2026-05-26 Drug product 2014-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 9555027 2026-05-26 U-543 Drug product 2017-03-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 9907794 2026-05-26 Drug product 2018-03-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 8729085*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 8883794*PED 2026-11-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 9907794*PED 2026-11-26 Pediatric extension 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 120 observed states.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Latuda LURASIDONE HYDROCHLORIDE Sumitomo Pharma America, Inc. afad3051-9df2-4c54-9684-e8262a133af8 2025-01-31 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 200603 application number: NDA200603
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70518-1936-0 70518193600 30 POUCH in 1 BOX, UNIT-DOSE (70518-1936-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-1936-1) 30 pouch 2019-03-06 0000-00-00 No No Current